Richard Schmid, DDS
Oral and Maxillofacial Surgery · Melbourne, FLNPI 1740458934
Payments from drug & device makers
Across 21 payments — averaging $45.76 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Johnson & Johnson$615
- Biohorizons Implant Systems Inc.$102
- Zimvie Inc.$73
- Zimmer Biomet$59
- Nobel Biocare USA$55
- Geistlich Pharma, North America, Inc.$36
- plus $20 from 1 others
What the payments were for
- Food & beverage$961100%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Johnson & Johnson | 6 | $615 |
| Biohorizons Implant Systems Inc. | 3 | $102 |
| Zimvie Inc. | 3 | $73 |
| Zimmer Biomet | 2 | $59 |
| Nobel Biocare USA | 3 | $55 |
| Geistlich Pharma, North America, Inc. | 3 | $36 |
| Highridge Medical LLC | 1 | $20 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- TRUMATCH$243
- MATRIXORTHOGNATHIC$113
How this compares
$961 in reported general payments places this provider in the 55th percentile of 498 oral and maxillofacial surgery providers in Florida.
See all oral and maxillofacial surgery providers in Florida →
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Dexamethasone | 70 | $2,485 |
| Chlorhexidine Gluconate | 191 | $898 |
| Amoxicillin | 130 | $406 |
| Hydrocodone-AcetaminophenHydrocodone/Acetaminophen | 97 | $324 |
| Clindamycin Hcl | 22 | $232 |
| Ibuprofen | 54 | $109 |
| Oxycodone-AcetaminophenOxycodone Hcl/Acetaminophen | 14 | $50 |
| Tramadol Hcl | 21 | $45 |
Paid to pharmacies, not to this prescriber.
Other oral and maxillofacial surgery in Melbourne
- Michael PikosPalm Harbor$3M
- Ramon RuizOrlando$846K
- Curtis SchalitDaytona Beach$333K
- Alessandro VillaMiami$126K
- Rui FernandesJacksonville$107K
- Tyler HolleyOrlando$55K
- Shaun YoungNew Port Richey$46K
- Eduardo NicolaievskyMiami Beach$45K
- Craig MischSarasota$43K
- Jose MonteroMiami$42K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.